Overview

Atomoxetine Treatment for ADHD and Marijuana Dependence

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to determine if atomoxetine treatment combined with motivational enhancement therapy is effective in reducing marijuana use in adult individuals with attention-deficit hyperactivity disorder and marijuana dependence.
Phase:
Phase 2
Details
Lead Sponsor:
Medical University of South Carolina
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Atomoxetine Hydrochloride